United Kingdom · Question · Written question
UIN 26382
Alzheimer's Disease: Medical Treatments
Introduced
24 January 2025
Last action
30 January 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 January 2025
Summary
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 January 2025
Written question
To ask the Secretary of State for Health and Social Care, if he will have discussions with (a) Eisai Co., Ltd and Biogen Inc. and (b) Eli Lilly and Company on the production of disease-modifying treatments for Alzheimer's disease in the UK.
Source: Commons
30 January 2025
Answer
The Government deeply values its relationships with life science companies and is committed to getting treatments to National Health Service patients through our 10 Year Plan for the NHS. This will include a plan for procurement, giving a clearer route to...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-01-24/26382
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1758622
- uk · wq-1758622 · source updated 30 January 2025